{"text": "the data has been extremely compelling says biib ceo chris viehbacher on s new alzheimer s drug somewhere towards the latter half of this year the product will be reimbursed sales will take off when we get the cms approval"}
{"text": "good morning our jpm23 coverage starts in minutes on first up gild ceo dan o day then in the 8amet 5ampt hour new biib ceo chris viehbacher what do you want to know"}
{"text": "ions and rprx enter into royalty agreement for up to 1 1 billion rprx to acquire an interest in spinraza and pelacarsen royalties ions retains majority of royalties and all milestones from nvs for pelacarsen rprx to pay ionis 500m upfront biib"}
{"text": "jpm23 day 1 tomorrow what public co presentations are you most looking forwarding to me will biib give insights on leqembi cms coverage will apls shed light on timing of cmo departure will verv provide update on us clinical hold hon mention has regn filed hd eylea"}
{"text": "new biogen biib ceo new drug launches more cost cuts but no radical left turns needed jpm23"}
{"text": "good morning snapshot of this morning s pre market darkpool activity dash msft jnj wmt biib pfe ttwo ew"}
